Bath emollients are non-formulary and are not recommended by C&H CCG. An appropriate emollient (e.g. emulsifying ointment) should be used in warm bath water rather than a specific bath emollient product. Bath emollients can be prescribed in exceptional circumstances when this is recommended by a dermatologist for a child; a cost-effective choice should be made (e.g. not Aveeno® bath emollient).

People without a diagnosed dermatological condition requesting a general skin moisturiser may purchase these over the counter and should be encouraged to do so. 

Emollients should only be prescribed for people with a diagnosed dermatological condition or if skin integrity is at risk through xerosis or pruritus. Please refer to the emollient guideline and formulary for more information.

Please see the emollient guideline and eczema guideline for further information. Please note products that are not listed in these guidelines (but are on formulary) should be prescribed under the advice of a dermatology specialist. 

• Guidelines for the management of atopic eczema in primary care
• Emollient guideline and formulary

Bath emollients are non-formulary and are not recommended by C&H CCG. An appropriate emollient (e.g. emulsifying ointment) should be used in warm bath water rather than a specific bath emollient product. Bath emollients can be prescribed in exceptional circumstances when this is recommended by a dermatologist for a child; a cost-effective choice should be made (e.g. not Aveeno® bath emollient).

People without a diagnosed dermatological condition requesting a general skin moisturiser may purchase these over the counter and should be encouraged to do so. 

Emollients should only be prescribed for people with a diagnosed dermatological condition or if skin integrity is at risk through xerosis or pruritus. Please refer to the emollient guideline and formulary for more information.

Please see the emollient guideline and eczema guideline for further information. Please note products that are not listed in these guidelines (but are on formulary) should be prescribed under the advice of a dermatology specialist. 

• Guidelines for the management of atopic eczema in primary care
• Emollient guideline and formulary

Bath emollients are non-formulary and are not recommended by C&H CCG. An appropriate emollient (e.g. emulsifying ointment) should be used in warm bath water rather than a specific bath emollient product. Bath emollients can be prescribed in exceptional circumstances when this is recommended by a dermatologist for a child; a cost-effective choice should be made (e.g. not Aveeno® bath emollient).

People without a diagnosed dermatological condition requesting a general skin moisturiser may purchase these over the counter and should be encouraged to do so. 

Emollients should only be prescribed for people with a diagnosed dermatological condition or if skin integrity is at risk through xerosis or pruritus. Please refer to the emollient guideline and formulary for more information.

Please see the emollient guideline and eczema guideline for further information. Please note products that are not listed in these guidelines (but are on formulary) should be prescribed under the advice of a dermatology specialist. 

• Guidelines for the management of atopic eczema in primary care
• Emollient guideline and formulary

Bath emollients are non-formulary and are not recommended by C&H CCG. An appropriate emollient (e.g. emulsifying ointment) should be used in warm bath water rather than a specific bath emollient product. Bath emollients can be prescribed in exceptional circumstances when this is recommended by a dermatologist for a child; a cost-effective choice should be made (e.g. not Aveeno® bath emollient).

People without a diagnosed dermatological condition requesting a general skin moisturiser may purchase these over the counter and should be encouraged to do so. 

Emollients should only be prescribed for people with a diagnosed dermatological condition or if skin integrity is at risk through xerosis or pruritus. Please refer to the emollient guideline and formulary for more information.

Please see the emollient guideline and eczema guideline for further information. Please note products that are not listed in these guidelines (but are on formulary) should be prescribed under the advice of a dermatology specialist. 

• Guidelines for the management of atopic eczema in primary care
• Emollient guideline and formulary

Bath emollients are non-formulary and are not recommended by C&H CCG. An appropriate emollient (e.g. emulsifying ointment) should be used in warm bath water rather than a specific bath emollient product. Bath emollients can be prescribed in exceptional circumstances when this is recommended by a dermatologist for a child; a cost-effective choice should be made (e.g. not Aveeno® bath emollient).

People without a diagnosed dermatological condition requesting a general skin moisturiser may purchase these over the counter and should be encouraged to do so. 

Emollients should only be prescribed for people with a diagnosed dermatological condition or if skin integrity is at risk through xerosis or pruritus. Please refer to the emollient guideline and formulary for more information.

Please see the emollient guideline and eczema guideline for further information. Please note products that are not listed in these guidelines (but are on formulary) should be prescribed under the advice of a dermatology specialist. 

• Guidelines for the management of atopic eczema in primary care
• Emollient guideline and formulary

Bath emollients are non-formulary and are not recommended by C&H CCG. An appropriate emollient (e.g. emulsifying ointment) should be used in warm bath water rather than a specific bath emollient product. Bath emollients can be prescribed in exceptional circumstances when this is recommended by a dermatologist for a child; a cost-effective choice should be made (e.g. not Aveeno® bath emollient).

People without a diagnosed dermatological condition requesting a general skin moisturiser may purchase these over the counter and should be encouraged to do so. 

Emollients should only be prescribed for people with a diagnosed dermatological condition or if skin integrity is at risk through xerosis or pruritus. Please refer to the emollient guideline and formulary for more information.

Please see the emollient guideline and eczema guideline for further information. Please note products that are not listed in these guidelines (but are on formulary) should be prescribed under the advice of a dermatology specialist. 

• Guidelines for the management of atopic eczema in primary care
• Emollient guideline and formulary

Bath emollients are non-formulary and are not recommended by C&H CCG. An appropriate emollient (e.g. emulsifying ointment) should be used in warm bath water rather than a specific bath emollient product. Bath emollients can be prescribed in exceptional circumstances when this is recommended by a dermatologist for a child; a cost-effective choice should be made (e.g. not Aveeno® bath emollient).

People without a diagnosed dermatological condition requesting a general skin moisturiser may purchase these over the counter and should be encouraged to do so. 

Emollients should only be prescribed for people with a diagnosed dermatological condition or if skin integrity is at risk through xerosis or pruritus. Please refer to the emollient guideline and formulary for more information.

Please see the emollient guideline and eczema guideline for further information. Please note products that are not listed in these guidelines (but are on formulary) should be prescribed under the advice of a dermatology specialist. 

• Guidelines for the management of atopic eczema in primary care
• Emollient guideline and formulary

Bath emollients are non-formulary and are not recommended by C&H CCG. An appropriate emollient (e.g. emulsifying ointment) should be used in warm bath water rather than a specific bath emollient product. Bath emollients can be prescribed in exceptional circumstances when this is recommended by a dermatologist for a child; a cost-effective choice should be made (e.g. not Aveeno® bath emollient).

People without a diagnosed dermatological condition requesting a general skin moisturiser may purchase these over the counter and should be encouraged to do so. 

Emollients should only be prescribed for people with a diagnosed dermatological condition or if skin integrity is at risk through xerosis or pruritus. Please refer to the emollient guideline and formulary for more information.

Please see the emollient guideline and eczema guideline for further information. Please note products that are not listed in these guidelines (but are on formulary) should be prescribed under the advice of a dermatology specialist. 

• Guidelines for the management of atopic eczema in primary care
• Emollient guideline and formulary

Bath emollients are non-formulary and are not recommended by C&H CCG. An appropriate emollient (e.g. emulsifying ointment) should be used in warm bath water rather than a specific bath emollient product. Bath emollients can be prescribed in exceptional circumstances when this is recommended by a dermatologist for a child; a cost-effective choice should be made (e.g. not Aveeno® bath emollient).

People without a diagnosed dermatological condition requesting a general skin moisturiser may purchase these over the counter and should be encouraged to do so. 

Emollients should only be prescribed for people with a diagnosed dermatological condition or if skin integrity is at risk through xerosis or pruritus. Please refer to the emollient guideline and formulary for more information.

Please see the emollient guideline and eczema guideline for further information. Please note products that are not listed in these guidelines (but are on formulary) should be prescribed under the advice of a dermatology specialist. 

• Guidelines for the management of atopic eczema in primary care
• Emollient guideline and formulary

Bath emollients are non-formulary and are not recommended by C&H CCG. An appropriate emollient (e.g. emulsifying ointment) should be used in warm bath water rather than a specific bath emollient product. Bath emollients can be prescribed in exceptional circumstances when this is recommended by a dermatologist for a child; a cost-effective choice should be made (e.g. not Aveeno® bath emollient).

People without a diagnosed dermatological condition requesting a general skin moisturiser may purchase these over the counter and should be encouraged to do so. 

Emollients should only be prescribed for people with a diagnosed dermatological condition or if skin integrity is at risk through xerosis or pruritus. Please refer to the emollient guideline and formulary for more information.

Please see the emollient guideline and eczema guideline for further information. Please note products that are not listed in these guidelines (but are on formulary) should be prescribed under the advice of a dermatology specialist. 

• Guidelines for the management of atopic eczema in primary care
• Emollient guideline and formulary

Bath emollients are non-formulary and are not recommended by C&H CCG. An appropriate emollient (e.g. emulsifying ointment) should be used in warm bath water rather than a specific bath emollient product. Bath emollients can be prescribed in exceptional circumstances when this is recommended by a dermatologist for a child; a cost-effective choice should be made (e.g. not Aveeno® bath emollient).

People without a diagnosed dermatological condition requesting a general skin moisturiser may purchase these over the counter and should be encouraged to do so. 

Emollients should only be prescribed for people with a diagnosed dermatological condition or if skin integrity is at risk through xerosis or pruritus. Please refer to the emollient guideline and formulary for more information.

Please see the emollient guideline and eczema guideline for further information. Please note products that are not listed in these guidelines (but are on formulary) should be prescribed under the advice of a dermatology specialist. 

• Guidelines for the management of atopic eczema in primary care
• Emollient guideline and formulary

People without a diagnosed dermatological condition requesting a general skin moisturiser may purchase these over the counter and should be encouraged to do so. 

Emollients should only be prescribed for people with a diagnosed dermatological condition or if skin integrity is at risk through xerosis or pruritus. Please refer to the emollient guideline and formulary for more information.

Please see the emollient guideline and eczema guideline for further information. Please note products that are not listed in these guidelines (but are on formulary) should be prescribed under the advice of a dermatology specialist. 

• Guidelines for the management of atopic eczema in primary care
• Emollient guideline and formulary

Colloidal oatmeal-containing emollients (Aveeno®) should only be prescribed for endogenous and exogenous eczema, xeroderma, ichthyosis and senile pruritus associated with dry skin.

People without a diagnosed dermatological condition requesting a general skin moisturiser may purchase these over the counter and should be encouraged to do so. 

Emollients should only be prescribed for people with a diagnosed dermatological condition or if skin integrity is at risk through xerosis or pruritus. Please refer to the emollient guideline and formulary for more information.

Please see the emollient guideline and eczema guideline for further information. Please note products that are not listed in these guidelines (but are on formulary) should be prescribed under the advice of a dermatology specialist. 

• Guidelines for the management of atopic eczema in primary care
• Emollient guideline and formulary

June 2019 - the JPG agreed to approved the addition of Adex® gel to the joint formulary for dry skin conditions associated with inflammation and redness that would benefit from a steroid-free emollient with an added anti-inflammatory effect.

People without a diagnosed dermatological condition requesting a general skin moisturiser may purchase these over the counter and should be encouraged to do so. 

Emollients should only be prescribed for people with a diagnosed dermatological condition or if skin integrity is at risk through xerosis or pruritus. Please refer to the emollient guideline and formulary for more information.

Please see the emollient guideline and eczema guideline for further information. Please note products that are not listed in these guidelines (but are on formulary) should be prescribed under the advice of a dermatology specialist. 

• Guidelines for the management of atopic eczema in primary care
• Emollient guideline and formulary

People without a diagnosed dermatological condition requesting a general skin moisturiser may purchase these over the counter and should be encouraged to do so. 

Emollients should only be prescribed for people with a diagnosed dermatological condition or if skin integrity is at risk through xerosis or pruritus. Please refer to the emollient guideline and formulary for more information.

Please see the emollient guideline and eczema guideline for further information. Please note products that are not listed in these guidelines (but are on formulary) should be prescribed under the advice of a dermatology specialist. 

• Guidelines for the management of atopic eczema in primary care
• Emollient guideline and formulary

People without a diagnosed dermatological condition requesting a general skin moisturiser may purchase these over the counter and should be encouraged to do so. 

Emollients should only be prescribed for people with a diagnosed dermatological condition or if skin integrity is at risk through xerosis or pruritus. Please refer to the emollient guideline and formulary for more information.

Please see the emollient guideline and eczema guideline for further information. Please note products that are not listed in these guidelines (but are on formulary) should be prescribed under the advice of a dermatology specialist. 

• Guidelines for the management of atopic eczema in primary care
• Emollient guideline and formulary

Dose escalation of Adalimumab is approved for Crohn's disease and ulcerative colitis

November 2022 - The North East London Formulary & Pathways Group (FPG) approved the use of Betesil® (Betamethasone valerate) 2.25mg medicated plasters. This is indicated for the treatment of inflammatory skin disorders which do not respond to treatment with less potent corticosteroids, such as eczema, lichenification, lichen planus, granuloma annulare, palmoplantar pustulosis and mycosis fungoides.

Formulary status: Amber (specialist knowledge/initiation) - to be initiated by or on recommendation of a dermatologist or GPwSI in dermatology.

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

• Shared Care Guidelines
• Inappropriate request communication form

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

• Shared Care Guidelines
• Inappropriate request communication form

Benepali (etanercept biosimilar) is the formulary choice brand of Etanercept

Benepali (etanercept biosimilar) is the formulary choice brand of Etanercept

Benepali (etanercept biosimilar) is the formulary choice brand of Etanercept

Benepali (etanercept biosimilar) is the formulary choice brand of Etanercept

Benepali (etanercept biosimilar) is the formulary choice brand of Etanercept

Happy to prescribe

If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. 

Unhappy to prescribe

If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. 

• Shared Care Guidelines
• Inappropriate request communication form

Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:

• there are differences in bioavailability between brands of the same medicine
• modified-release (MR) preparations that are not interchangeable
• administration devices have different instructions for use and patient familiarity with one product is important
• there are important differences in formulation between brands of the same medicine
• branded and generic preparations have different licensed indications
• products contain more than one ingredient and brand-name prescribing aids identification.

Please prescribe this product by brand.

Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:

• there are differences in bioavailability between brands of the same medicine
• modified-release (MR) preparations that are not interchangeable
• administration devices have different instructions for use and patient familiarity with one product is important
• there are important differences in formulation between brands of the same medicine
• branded and generic preparations have different licensed indications
• products contain more than one ingredient and brand-name prescribing aids identification.

Please prescribe this product by brand.